Fulgent Genetics (FLGT) EBITDA Margin (2015 - 2026)
Fulgent Genetics' (FLGT) quarterly EBITDA Margin came in at 48.67% in Q1 2026, down 2172.0% year-on-year from 2.35% in Q1 2025, and up 61.06% quarter-over-quarter from 125.0% in Q4 2025.
Fulgent Genetics (FLGT) EBITDA Margin (2015 - 2026) Analysis & Trends
Fulgent Genetics has disclosed EBITDA Margin across 12 years of filings, most recently posting 48.67% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 48.67%, down 2172.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 29.56% (down 497.0% YoY), and the FY2025 annual result was 4.56%, up 2152.0% from the prior year.
- EBITDA Margin came in at 48.67% for Q1 2026 at Fulgent Genetics, up from 125.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 63.05% in Q1 2022 to a low of 214.34% in Q4 2023.
- The 5-year median for EBITDA Margin is 25.36% (2024), against an average of 34.72%.
- Across the five-year window, EBITDA Margin jumped 19317 bps in 2024 and slumped 10383 bps in 2025, its largest moves.
- Fulgent Genetics' EBITDA Margin stood at 0.33% in 2022, then sank by 64436 bps to 214.34% in 2023, then surged by 90 bps to 21.17% in 2024, then slumped by 490 bps to 125.0% in 2025, then soared by 61 bps to 48.67% in 2026.
- The last three EBITDA Margin figures came in at 48.67% (Q1 2026), 125.0% (Q4 2025), and 18.26% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.21% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 19.42% |
| 10 | Fulgent Genetics | 570.68 Mn | 288.72 Mn | 21.49 Mn | -48.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.67% |
| Dec 31, 2025 | -125.00% |
| Sep 30, 2025 | -18.26% |
| Jun 30, 2025 | -24.10% |
| Mar 31, 2025 | -26.95% |
| Dec 31, 2024 | -21.17% |
| Sep 30, 2024 | -23.81% |
| Jun 30, 2024 | -26.62% |
| Mar 31, 2024 | -33.80% |
| Dec 31, 2023 | -214.34% |
| Sep 30, 2023 | 0.25% |
| Jun 30, 2023 | -29.18% |
| Mar 31, 2023 | -37.52% |
| Sep 30, 2022 | 0.33% |
| Jun 30, 2022 | 10.21% |
| Mar 31, 2022 | 63.05% |
| Dec 31, 2021 | 59.94% |
| Sep 30, 2021 | 69.90% |
| Jun 30, 2021 | 64.38% |
| Mar 31, 2021 | 74.26% |